您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览163

Blood levels of triglyceride-rich lipoproteins (TRL) increase postprandially, and a delay in their clearance results in postprandial hyperlipidemia, an important risk factor in atherosclerosis development. Atherosclerosis is a multifactorial inflammatory disease, and its initiation involves endothelial dysfunction, invasion of the artery wall by leukocytes and subsequent formation of foam cells. TRL are implicated in several of these inflammatory processes, including the formation of damaging free radicals, leukocyte activation, endothelial dysfunction and foam cell formation. Recent studies have provided insights into the mechanisms of uptake and the signal transduction pathways mediating the interactions of TRL with leukocytes and vascular cells, and how they are modified by dietary lipids. Multiple receptor and non-receptor mediated pathways function in macrophage uptake of TRL. TRL also induce expression of adhesion molecules, cyclooxygenase-2 and heme-oxygenase-1 in endothelial cells, and activate intracellular signaling pathways involving mitogen-activated protein kinases, NF-κB and Nrf2. Many of these effects are strongly influenced by dietary components carried in TRL. There is extensive evidence indicating that raised postprandial TRL levels are a risk factor for atherosclerosis, but the molecular mechanisms involved are only now becoming appreciated. Here, we review current understanding of the mechanisms by which TRL influence vascular cell function.

作者:Kathleen M, Botham;Caroline P D, Wheeler-Jones

来源:Progress in lipid research 2013 年 52卷 4期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:163
作者:
Kathleen M, Botham;Caroline P D, Wheeler-Jones
来源:
Progress in lipid research 2013 年 52卷 4期
标签:
1-palmitoyl-2-arachidonyl-sn-glycerol-3-phosphocholine ABC AMP kinase AMPK AP ATP binding cassette transporter Akt Apo C reactive protein CD CM CMR COX CREB CRP DHA EC EGF EPA EPC ERK Egr Endothelial cells FAK FFA GPIHBP1 HAEC HDL HMDM HO HSPG HUVEC ICAM IFN IL Inflammation IκB JNK LDL LDLR LOX LPL LPS LR11 LRP M1 M2 MAPK MCP MEK MIP MMP MUFA Macrophages Monocytes Mox NAD(P)H oxidase NF-κB NO Nox Nrf P PAI-1 PAPC PGE(2) PKC PL POA PPAR PUFA Postprandial lipemia RAP RLP ROS RXR SFA SR TG TGF TLR TNF TRL Triglyceride-rich lipoproteins V VCAM VE cadherin VEGF VLDL VLDLR VSMC activator protein alternatively activated macrophages apoB48R apolipoprotein apolipoprotein B48 receptor c-Jun N-terminal kinase cAMP response element binding chylomicron remnants chylomicrons classically activated macrophages cluster of differentiation cyclooxygenase docosahexaenoic acid eNOS early growth response protein eicosapentaenoic acid endothelial cell endothelial nitric oxide synthase endothelial progenitor cell epidermal growth factor extracellular-signal-regulated kinase focal adhesion kinase free fatty acid glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 hemeoxygenase heparan sulfate proteoglycans high density lipoprotein human aortic endothelial cell human monocyte-derived macrophages human umbilical vein endothelial cells inhibitor of κB intercellular adhesion molecule interferon interleukin lectin-like oxidized low density lipoprotein receptor lipopolysaccharide lipoprotein lipase low density lipoprotein low density lipoprotein receptor low density lipoprotein receptor-related protein macrophage inflammatory protein macrophage phenotype induced by oxidised phospholipids matrix-metalloproteinase mitogen activated protein kinase kinase mitogen-activated kinase monocyte chemoattractant protein monousaturated fatty acids nitric oxide nuclear factor (erythroid-derived 2)-like 2 nuclear factor-κB ox oxidized peroxisome proliferator-activated receptor phospholipid plasminogen activator inhibitor type 1 polyunsaturated fatty acids pomace oil supplemented with oleanolic acid test meal pomace olive oil test meal prostglandin E2 protein kinase B protein kinase C reactive oxygen species receptor associated protein remnant-like particles retinoid X receptor saturated fatty acids scavenger receptor sortilin-related receptor toll-like receptor transforming growth factor triacylglycerol triglyceride-rich lipoproteins tumor necrosis factor vascular cell adhesion molecule vascular endothelial cadherin vascular endothelial growth factor vascular smooth muscle cells very low density lipoprotein very low density lipoprotein receptor virgin olive oil test meal
Blood levels of triglyceride-rich lipoproteins (TRL) increase postprandially, and a delay in their clearance results in postprandial hyperlipidemia, an important risk factor in atherosclerosis development. Atherosclerosis is a multifactorial inflammatory disease, and its initiation involves endothelial dysfunction, invasion of the artery wall by leukocytes and subsequent formation of foam cells. TRL are implicated in several of these inflammatory processes, including the formation of damaging free radicals, leukocyte activation, endothelial dysfunction and foam cell formation. Recent studies have provided insights into the mechanisms of uptake and the signal transduction pathways mediating the interactions of TRL with leukocytes and vascular cells, and how they are modified by dietary lipids. Multiple receptor and non-receptor mediated pathways function in macrophage uptake of TRL. TRL also induce expression of adhesion molecules, cyclooxygenase-2 and heme-oxygenase-1 in endothelial cells, and activate intracellular signaling pathways involving mitogen-activated protein kinases, NF-κB and Nrf2. Many of these effects are strongly influenced by dietary components carried in TRL. There is extensive evidence indicating that raised postprandial TRL levels are a risk factor for atherosclerosis, but the molecular mechanisms involved are only now becoming appreciated. Here, we review current understanding of the mechanisms by which TRL influence vascular cell function.